Clinical Trials Browser

Terminated × TIC10 compound × Gynecologic × Clear all

NCT03099499 2024-12-24

Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

Phase 2 Terminated

Endometrial Neoplasms

NCT03485729 2024-12-24

ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

Phase 2 Terminated

27 enrolled 11 charts

Endometrial Cancer Recurrent